Staging and Management of Chronic Kidney Disease

Primer on Kidney Diseases

Volumn , Issue , 2009, Pages 436-445

  Stevens, Lesley A ^a,b   Stoycheff, Nicholas ^b   Levey, Andrew S ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85153817787     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-5185-5.00053-5     Document Type: Chapter

References (20)

1. J. Coresh, E. Selvin, L.A. Stevens, et al. (2007) Prevalence of chronic kidney disease in the U.S. during 1988-1994 and 1999-2004. JAMA 298 2038-2047.
2. G. Eknoyan, T. Hostetter, G. Bakris, et al. (2003) Proteinuria and other markers of chronic kidney disease: A position statement of the National Kidney Foundation (NKF) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Am J Kidney Dis 42 617-622.
3. A. Go, G.M. Chertow, D. Fan, et al. (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 1296-1305.
4. T. Jafar, P. Stark, C. Schmid, et al. (2003) Progression of chronic kidney disease: The role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition—A patient-level meta-analysis. Ann Intern Med 139 244-252.
5. S. Klahr, A.S. Levey, G.J. Beck, et al. (1994) The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 330 877-884.
6. A. Levey, J. Coresh, E. Balk, et al. (2003) National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 139 137-147.
7. A.S. Levey, J. Coresh, T. Greene, et al. (2006) Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate. Ann Intern Med 145 247-254.
8. A. Levin, M. Lewis, P. Mortiboy, et al. (1997) Multidisciplinary predialysis programs: Quantification and limitations of their impact on patient outcomes in two Canadian settings. Am J Kidney Dis 29 533-540.
9. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1), S1-S266.
10. National Kidney Foundation (2004) K/DOQI clinical practice guidelines for hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 43(5 Suppl 1), S1-S290.
11. A. O’Hare, D. Bertenthal, K.E. Covinsky, et al. (2006) Mortality risk stratification in chronic kidney disease: One size for all ages? J Am Soc Nephrol 17 846-853.
12. M.J. Sarnak, T. Greene, X. Wang, et al. (2005) The effect of a lower target blood pressure on the progression of kidney disease: Long-term follow-up of the modification of diet in renal disease study. Ann Intern Med 142 342-351.
13. M. Sarnak, A. Levey, A. Schoolwerth, et al. (2003) Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 42 1050-1065.
14. Standards of medical care in diabetes—2007 (2007) Diabetes Care 30(Suppl 1), S4-S41.
15. L.A. Stevens, J. Coresh, H.I. Feldman, et al. (2007) Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol 18 2749-2757.
16. L.A. Stevens, J. Coresh, T. Greene, et al. (2006) Assessing kidney function: Measured and estimated glomerular filtration rate. N Engl J Med 354 2473-2483.
17. L.A. Stevens, J. Manzi, A.S. Levery, et al. (2007) Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. Am J Kidney Dis 50 21-35.
18. United Kingdom Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 837-853.
19. United States Renal Data System: USRDS 2007 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2007.
20. J.A. Vassalotti, L.A. Stevens and A.S. Levey (2007) Testing for chronic kidney disease: A position statement from the National Kidney Foundation. Am J Kidney Dis 50 169-180.